Cargando…
PM524. VEGF may have a neuroprotective role in the improvement of schizophrenia or in the treatment effects of antipsychotics
Autores principales: | Kim, Yongku, Ham, Byung-Joo, Hong, Jin-Pyo, Kim, Won-Joong, Lee, Bun-Hee, Na, Kyoung-Sae, Trigo, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616457/ http://dx.doi.org/10.1093/ijnp/pyw041.524 |
Ejemplares similares
-
Neuroprotection in Schizophrenia and Its Therapeutic Implications
por: Kim, Yong-Ku, et al.
Publicado: (2017) -
PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016) -
Battery Electrolytes: High‐Performance Lithium‐Oxygen Battery Electrolyte Derived from Optimum Combination of Solvent and Lithium Salt (Adv. Sci. 10/2017)
por: Ahn, Su Mi, et al.
Publicado: (2017) -
High‐Performance Lithium‐Oxygen Battery Electrolyte Derived from Optimum Combination of Solvent and Lithium Salt
por: Ahn, Su Mi, et al.
Publicado: (2017) -
Testing the Neuroprotective Properties of PCSO-524(®) Using a Neuronal Cell Cycle Suppression Assay
por: Zhu, Beika, et al.
Publicado: (2019)